Addex Therapeutics Ltd Investments In Associates Accounted For Using Equity Method
Addex Therapeutics Ltd (ADXN) had Investments In Associates Accounted For Using Equity Method of CHF 5.01 million as of 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Notes
ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod · last filed 2025-09-30
- 2025-06-30: Investments In Associates Accounted For Using Equity Method 5.01M CHF.
- 2024-12-31: Investments In Associates Accounted For Using Equity Method 7.09M CHF.
| Period end | Investments In Associates Accounted For Using Equity Method |
|---|---|
| 2025-06-30 | 5.01M CHF 6-K · filed 2025-09-30 |
| 2024-12-31 | 7.09M CHF 6-K · filed 2025-09-30 |